Raily Aesthetic Medicine International Holdings Limited

HKEX:2135.HK

0.137 (HKD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q2
Operating Activities:
Net Income -32.628-2.55-19.5161.79-15.073-6.284
Depreciation & Amortization 14.51914.41213.73313.2279.4828.032
Deferred Income Tax 000000
Stock Based Compensation 000000
Change In Working Capital 7.591-5.8148.906-17.81823.07-19.109
Accounts Receivables 2.705-8.323.536-11.31916.888-13.046
Change In Inventory 0.3040.931-4.5495.1224.091-4.211
Change In Accounts Payables -0.440.8-4.2560.4441.303-0.809
Other Working Capital 5.0220.77614.175-12.0660.789-1.044
Other Non Cash Items 38.12837.31827.62634.66-5.14432.403
Operating Cash Flow 1.1417.952-1.987-0.34915.652-19.087
Investing Activities:
Investments In Property Plant And Equipment -10.202-9.268-10.822-10.333-15.442-3.656
Acquisitions Net 0.2990.04300-25.1470.128
Purchases Of Investments 12.925-37.773-13.571-14.514-29.605-75.335
Sales Maturities Of Investments 2.11112.815-10.7560.1311.95341.599
Other Investing Activites 00-0-000
Investing Cash Flow 5.134-34.183-35.14335.283-58.241-37.264
Financing Activities:
Debt Repayment -4.738-6.899-4.904-21.73600
Common Stock Issued 00000.09811.342
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0-5.155-6.802000
Financing Cash Flow -12.691.744-1.898-26.6150.759.899
Other Information:
Effect Of Forex Changes On Cash 037.346-19.9833.36500
Net Change In Cash -16.63412.859-59.0111.684-79.918-46.452
Cash At End Of Period 45.55462.18949.33108.3496.656176.575